The American College of Cardiology and the American Heart Association, collaborating with the American Medical Association\u2019s Physician Consortium for Performance Improvement (PCPI), have drafted an updated set of clinical performance measures for assessing and improving the quality of ambulatory care of patients with hypertension and stable coronary artery disease. These measures, which assess processes of care (e.g., medication prescription) and intermediate outcomes (e.g., risk factor levels), are designed to address either quality improvement or accountability. They will be submitted for endorsement by the National Quality Forum (NQF) when completed. <\/p>\n
The measures defined in each condition are listed below. An * indicates a new measure introduced since the last update.<\/p>\n
A) Hypertension<\/strong> <\/p>\n Measure #1: Blood pressure control <\/p>\n Measure #1: Blood Pressure Control These measures were developed to support the delivery of high quality health care by meeting criteria in the Institute of Medicine’s six domains of quality improvement: Safe, Effective, Patient-centered, Timely, Efficient, and Equitable.<\/p>\n The ACC\/AHA\/PCPI have made draft versions of these measures available for public comment. All practitioners who care for outpatients with hypertension and coronary artery disease have an interest in understanding these measures and in providing recommendations on how to improve them. Make sure that your opinion is heard \u2014 visit http:\/\/www.ama-assn.org\/ama\/pub\/physician-resources\/clinical-practice-improvement\/clinical-quality\/physician-consortium-performance-improvement\/public-comments.shtml <\/a>to download draft versions of the measures and submit your comments. <\/p>\n Of course, we also welcome comment on these measures here in your responses to this post.<\/p>\n Dr. Masoudi is the Chair of the ACC\/AHA Performance Measures Task Force, which commissioned these measures in collaboration with the PCPI.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" The American College of Cardiology and the American Heart Association, collaborating with the American Medical Association\u2019s Physician Consortium for Performance Improvement (PCPI), have drafted an updated set of clinical performance measures for assessing and improving the quality of ambulatory care of patients with hypertension and stable coronary artery disease. These measures, which assess processes of care (e.g., medication prescription) […]<\/p>\n","protected":false},"author":661,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1444","post","type-post","status-publish","format-standard","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/661"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=1444"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1444\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=1444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=1444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=1444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nB) Coronary artery disease <\/strong><\/p>\n
\n Measure #2: Lipid Control
\n Measure #3: Symptom & Activity Assessment
\n Measure #4: Symptom Management*
\n Measure #5: Tobacco Cessation and Intervention
\n Measure #6: Antiplatelet Therapy
\n Measure #7: Beta-Blocker Therapy \u2014 Prior Myocardial Infarction or Left Ventricular Systolic Dysfunction (LVEF) <40%
\n Measure #8: ACE Inhibitor or ARB Therapy \u2014 Diabetes or LVEF <40%
\n Measure #9: Patient Referral to Cardiac Rehabilitation from an Outpatient Setting*
\n Measure #10: Overuse of Stress Testing* <\/p>\n